Zania Stamataki
Overview
Explore the profile of Zania Stamataki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
2512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Melidis L, Hill H, Coltman N, Davies S, Winczura K, Chauhan T, et al.
Angew Chem Weinheim Bergstr Ger
. 2024 Mar;
133(33):18292-18299.
PMID: 38505190
The untranslated regions (UTRs) of viral genomes contain a variety of conserved yet dynamic structures crucial for viral replication, providing drug targets for the development of broad spectrum anti-virals. We...
2.
Faustini S, Cook A, Hill H, Al-Taei S, Heaney J, Efstathiou E, et al.
J Infect
. 2023 Aug;
87(4):328-335.
PMID: 37543310
The importance of salivary SARS-CoV-2 antibodies, following infection and vaccination, has not been fully established. 875 healthcare workers were sampled during the first wave in 2020 and 66 longitudinally in...
3.
Warner S, Brown R, Reynolds G, Stamataki Z, Kelly D
Front Pediatr
. 2023 May;
11:1143051.
PMID: 37181429
The 2022 worldwide epidemic of acute hepatitis and liver failure in young children has led to a focus on unusual causes for childhood acute hepatitis. In the UK epidemic, human...
4.
Qi S, Kiratzis I, Adoni P, Tuekprakhon A, Hill H, Stamataki Z, et al.
ACS Appl Mater Interfaces
. 2023 Mar;
15(17):20638-20648.
PMID: 36988094
In the present work, we developed an effective antimicrobial surface film based on sustainable microfibrillated cellulose. The resulting porous cellulose thin film is barely noticeable to human eyes due to...
5.
Faustini S, Hall A, Brown S, Roberts S, Hill H, Stamataki Z, et al.
Br J Haematol
. 2023 Mar;
201(5):845-850.
PMID: 36895158
Multiple myeloma (MM) and anti-MM therapy cause profound immunosuppression, leaving patients vulnerable to coronavirus disease 2019 (COVID-19) and other infections. We investigated anti-severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies longitudinally...
6.
Mann J, Lenz D, Stamataki Z, Kelly D
Trends Mol Med
. 2022 Dec;
29(3):228-240.
PMID: 36496278
Acute liver failure (ALF) is a rare but potentially fatal disease in children. The etiology is multifactorial, including infection, autoimmune, and genetic disorders, as well as indeterminate hepatitis, which has...
7.
Ali A, Hill H, Elkhouly G, Bakkar M, Raya N, Stamataki Z, et al.
Antibiotics (Basel)
. 2022 Nov;
11(11).
PMID: 36358211
Hand hygiene is considered to be the key factor in controlling and preventing infection, either in hospital care settings or in the community. Alcohol-based hand sanitizers are commonly used due...
8.
Krysko O, Bourne J, Kondakova E, Galova E, Whitworth K, Newby M, et al.
Front Immunol
. 2022 Oct;
13:968981.
PMID: 36225927
Background: The systemic inflammatory response post-SARS-CoV-2 infection increases pro-inflammatory cytokine production, multi-organ damage, and mortality rates. Mast cells (MC) modulate thrombo-inflammatory disease progression (, deep vein thrombosis) and the inflammatory...
9.
Kelly D, Stamataki Z
Nat Rev Gastroenterol Hepatol
. 2022 Jul;
19(9):553-554.
PMID: 35778613
No abstract available.
10.
Shields A, Faustini S, Hill H, Al-Taei S, Tanner C, Ashford F, et al.
Front Immunol
. 2022 Jun;
13:912571.
PMID: 35720400
Background: Patients with primary and secondary antibody deficiency are vulnerable to COVID-19 and demonstrate diminished responses following two-dose SARS-CoV-2 vaccine schedules. Third primary vaccinations have been deployed to enhance their...